Furthermore, ORMDL3, which is highly expressed in asthma, exacerbates airway inflammation and remodelling by activating the JNK1/2–MMP-9 pathway, representing a potential novel therapeutic target for asthma treatment.94 The gene discussed is ORMDL3; the disease is asthma.